90 related articles for article (PubMed ID: 14534726)
1. Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines.
Iida K; Nobori T; Matsumine A; Isaka A; Seto M; Shiraishi T; Uchida A
Oncol Rep; 2003; 10(6):1961-5. PubMed ID: 14534726
[TBL] [Abstract][Full Text] [Related]
2. The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2.
Niu BH; Wang JJ; Xi Y; Ji XY
Med Sci Monit; 2010 Jun; 16(6):BR184-92. PubMed ID: 20512087
[TBL] [Abstract][Full Text] [Related]
3. Identification of drug-regulated genes in osteosarcoma cells.
Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
[TBL] [Abstract][Full Text] [Related]
5. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
Li W; Fan J; Hochhauser D; Banerjee D; Zielinski Z; Almasan A; Yin Y; Kelly R; Wahl GM; Bertino JR
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10436-40. PubMed ID: 7479800
[TBL] [Abstract][Full Text] [Related]
6. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
[TBL] [Abstract][Full Text] [Related]
8. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.
Mandic R; Schamberger CJ; Müller JF; Geyer M; Zhu L; Carey TE; Grénman R; Dünne AA; Werner JA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6845-52. PubMed ID: 16203773
[TBL] [Abstract][Full Text] [Related]
9. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
10. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.
Asada N; Tsuchiya H; Tomita K
Anticancer Res; 1999; 19(6B):5131-7. PubMed ID: 10697522
[TBL] [Abstract][Full Text] [Related]
11. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
Reed MF; Zagorski WA; Knudsen ES
J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
Li WW; Fan J; Hochhauser D; Bertino JR
Cancer Res; 1997 Jun; 57(11):2193-9. PubMed ID: 9187120
[TBL] [Abstract][Full Text] [Related]
13. Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells.
Wang JJ; Li GJ
Genet Mol Res; 2014 Jul; 13(3):5313-21. PubMed ID: 25078587
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
Levine RA; Fleischli MA
Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
17. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
18. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.
Chen R; Li X; He B; Hu W
Mol Med Rep; 2017 Mar; 15(3):1326-1334. PubMed ID: 28138700
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma cell lines display variable individual reactions on wildtype p53 and Rb tumour-suppressor transgenes.
Hellwinkel OJ; Müller J; Pollmann A; Kabisch H
J Gene Med; 2005 Apr; 7(4):407-19. PubMed ID: 15538723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
